Biblio Discovery — Demo Discovery Service

502 results

Showing 1–20 · 0.23 seconds · RSS

Journal

Cardio-Oncology

Scopus

ISSN 2057-3804 · BMC · 502 articles in the index

  1. Journal Article

    ST-elevation myocardial infarction halves expected survival in cancer patients even after effective revascularization

    Dorian Garin; Wesley Bennar; Serban Puricel et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The impact of ST-elevation myocardial infarction (STEMI) on cancer-specific survival remains poorly defined. We investigated whether successful primary percutaneous coronary intervention restores expected survival in cancer patients experiencing STEMI and assessed for potential…

  2. Journal Article

    Dexrazoxane Cardioprotection in pediatric ALL: a historical control cohort study

    Li Liu; Hongping Yang; Yan Zhou et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Objective This ambispective cohort study evaluates the effectiveness of cardioprotective strategies in reducing anthracycline-induced cardiotoxicity in pediatric patients with acute lymphoblastic leukemia (ALL). Methods We conducted a single-center, historically controlled ambispective…

  3. Journal Article

    Coronary artery calcification burden in cancer vs. non-cancer populations: a systematic review and meta-analysis

    James Hua Wang; Jacky Chen; Joshua Wong et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Coronary artery disease (CAD) events contribute to morbidity in cancer survivors, yet it is unclear whether this reflects increased atherosclerotic burden. Coronary artery calcium (CAC) scoring is a sensitive, non-invasive marker of atherosclerotic burden. This review aims to…

  4. Journal Article

    Cardiovascular risk factors and cardiac dysfunction in people with HIV and breast cancer: an observational cohort study in Botswana

    Henrietta Afari; Congying Xia; Julius Mwita et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background HIV, cancer, and their respective treatments are independently associated with cardiovascular risk, but limited data exist on the intersection of these conditions. The purpose of this study was to gain insights into the cardiovascular risk factor burden and cardiac function in…

  5. Journal Article

    Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis

    Abdelrahman El-Helbawy; Sara T. Zaki; Fouad Hanna et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Multiple chemotherapeutic agents, such as anthracyclines, have recently shown a fatal potential for cardiotoxic effects in their patients. However, their efficacy is often hindered by their harmful adverse effects, mostly cardiotoxicity. DM medications such as metformin, SGLT-2…

  6. Journal Article

    The ROOT-CTRCD study: exploring the relationship of oral health to cancer therapy-related cardiac dysfunction in HER2-positive breast cancer patients

    Ahmed Basuoni; Khalid Al-Baimani; Fatma AlKindi et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a significant complication of cancer therapy. While several factors contribute to its development, the role of oral health remains unexplored. This study examines the relationship between oral health, a potential modifiable…

  7. Journal Article

    Prevalence of obstructive coronary artery disease in asymptomatic cancer patients with elevated troponin levels

    Jannek Brauer; Sebastian W. Romann; Christian Stengele et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background High-sensitivity cardiac troponin T (hs-cTnT) is frequently elevated in cancer patients, but its clinical implications remain uncertain. We aimed to determine the prevalence of obstructive coronary artery disease (CAD) as a cause of hs-cTnT elevation and to evaluate the impact…

  8. Journal Article

    Can flaxseed “milk” prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)?

    Vibhuti Arya; Lana Mackic; Sara M. Telles Langdon et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Cardio-Oncology focuses on the prevention, diagnosis, and management of individuals with cancer who are at risk of developing cardiovascular complications as a result of their anti-cancer treatment. The aim of the “Can flaxseed “milk” prevent chemotherapy mediated cardiotoxicity…

  9. Journal Article

    Disparities in cardiovascular disease burden among Black and Hispanic survivors of adolescent and young adult (AYA) cancer

    Tori Tonn; Maanvi Thawani; Margaret Mazer et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Despite significant improvements in long-term survival outcomes for adolescents and young adults (AYAs) with cancer, common treatment regimens often pose substantial risks to the cardiovascular health of this survivor population. Differences in cardiovascular events by…

  10. Journal Article

    Cardioprotective medications and the incidence of cardiovascular events in patients treated with radiotherapy: a systematic review and meta-analysis

    Vishwa Pakeerathan; Ravi Marwah; Abdul Rahman Mohammed et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Purpose The purpose of this systematic review and meta-analysis is to explore the utilization of cardioprotective medications in patients treated with RT and assess their impact on cardiovascular and cerebrovascular events. Materials/methods A literature search of PubMed, Embase and Scopus…

  11. Journal Article

    Association of PCSK9 inhibitors versus statins with cancer incidence: a target trial emulation

    Chi-Hsien Huang; Shiow-Ing Wang; Frank S. Fan et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The relationship between PCSK9 inhibitors (PCSK9i) and cancer incidence remains poorly understood. This study is to investigate the association between PCSK9i use and cancer risk compared to statin therapy. Methods We conducted a retrospective cohort study using target trial…

  12. Journal Article

    Risk of incident cardiovascular disease events among older Asian, Native Hawaiian, and Pacific Islander colorectal cancer survivors in the United States: a cohort study

    Timothy Nguyen; Chun-Pin Esther Chang; Randa Tao et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Among Asian, Native Hawaiian, and Pacific Islanders (ANHPI) in the United States, cancer and cardiovascular disease are the leading causes of death. Colorectal cancer (CRC) is the third most common cancer among ANHPIs, with improving survival rates. However, the risk of…

  13. Journal Article

    Abemaciclib-induced myocarditis in early breast cancer: a case report

    Alexander JP Fulton; Mun Cheang; Maria TA Wetscherek et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Abemaciclib, a selective cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor, is standard adjuvant therapy for hormone receptor (HR)-positive, HER2-negative early breast cancer. While gastrointestinal and haematologic toxicities are well recognised, cardiotoxicity—particularly…

  14. Journal Article

    Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese

    Qun‑Yi Nian; Li-Wen Chang; Hui-Wen Yang et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Introduction Cardiovascular disease (CVD) remains one of the leading non-cancer causes of mortality in prostate cancer patients, with previous studies indicating that androgen deprivation therapy (ADT) may increase cardiovascular risk. In this study, we aimed to predict cardiovascular…

  15. Journal Article

    Multiple trait association analysis revealed common genetic loci between lung cancer and heart failure

    Linquan Mu; Yi zhou; Songpu Li et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Lung cancer (LC) and heart failure (HF) frequently co-occur with substantial clinical consequences, yet their shared genetic architecture remains poorly characterized. Emerging evidence suggests common pathophysiological pathways may underlie this comorbidity, particularly…

  16. Journal Article

    Statin initiation among cancer survivors with asymptomatic coronary atherosclerosis

    Cheng Hwee Soh; Shristy Shrestha; Kristyn Whitmore et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Cancer survivors are at higher risk of developing heart disease, but it is unclear whether they receive adequate preventive care. This study aimed to compare the statin initiation rates between cancer survivors and non-cancer controls. Methods Cancer survivors and similar…

  17. Journal Article

    Evaluating the safety and cardiac impact of resistance training in anthracycline-treated patients: a systematic review

    Johnny Huang; Rex Lam; Alice Pozza et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Anthracycline chemotherapy is commonly used to treat cancer in both adult and pediatric patients. While effective, anthracycline treatment is associated with a high risk of cardiotoxicity, often manifesting as a decline in left ventricular function, resulting in long term cardiovascular…

  18. Journal Article

    Associations of cardiovascular–kidney–metabolic syndrome stages with long-term mortality among US cancer survivors: a prospective cohort study

    Yangyang Zheng; Ting Li; Jinghai Song

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Introduction Cardiovascular-Kidney-Metabolic (CKM) syndrome is common among cancer survivors, largely driven by overlapping risk factors and therapy-induced toxicities; however, its contribution to long-term mortality has not been clarified. Methods From the 1999–2018 National Health and…

  19. Journal Article

    The impact of cardiac amyloidosis on patients with multiple myeloma: a systematic review and meta-analysis

    Giuseppina Novo; Francesco Stabile; Daniela Di Lisi et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Immunoglobulin light chain (AL) amyloidosis is a well-recognized complication of multiple myeloma (MM), with important prognostic implications. However, the effect of cardiac AL amyloidosis on survival in MM patients has been rarely investigated. Objective We aimed to perform a…

  20. Journal Article

    Two types amyloid infiltration of the heart: diagnostic challenges and therapeutic strategies

    Raúl Ramos-Polo; Santiago Jiménez-Marrero; Herminio Morillas et al.

    Cardio-Oncology, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Amyloidosis is characterized by extracellular deposition of insoluble fibrils, with light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) being the most common cardiac subtypes. Early detection and multimodal diagnostic strategies are critical for effective…